Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Endocrine 1CNS 1

Conditions

Lymphoma 50Breast Neoplasms 39Leukemia 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Multiple Myeloma 19Neuroblastoma 18Burkitt Lymphoma 17Lymphoma, Large B-Cell, Diffuse 15Lymphoma, Follicular 12Sarcoma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Leukemia, Biphenotypic, Acute 10Hodgkin Disease 10Central Nervous System Neoplasms 9Rhabdomyosarcoma 8Medulloblastoma 8Brain Neoplasms 7Wilms Tumor 6Myelodysplastic Syndromes 6Leukemia, Myeloid, Acute 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Inflammatory Breast Neoplasms 5Waldenstrom Macroglobulinemia 4Ovarian Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 4Malignant mesenchymal tumor 4Ganglioneuroblastoma 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

pegfilgrastim 1Suramin 1Platinum 1Mitotane 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Gene Expression Profiling 1Filgrastim 1Etoposide 1Ethane 1Doxorubicin 1Dichlorodiphenyldichloroethane 1DNA Methylation 1Cyclophosphamide 1Cisplatin 1Base Sequence 1Amplified Fragment Length Polymorphism Analysis 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Adrenocortical Carcinoma × Cyclophosphamide × Clear all
NCT01048892 2014-01-30

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

Children's Oncology Group

Phase 1 Completed
22 enrolled
CNSEndocrineGenitourinaryOther solid neoplasmSarcoma

Kidney Neoplasms, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡